Brickell Biotech Inc.

NASDAQ: BBI · Real-Time Price · USD
2.35
0.05 (2.17%)
At close: Sep 08, 2022, 6:00 AM

Brickell Biotech Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
404K
Cost of Revenue
n/a
Gross Profit
404K
Operating Income
-39.41M
Interest Income
n/a
Pretax Income
-39.47M
Net Income
-39.54M
Selling & General & Admin
12.42M
Research & Development
28.23M
Other Expenses
n/a
Operating Expenses
40.65M
Interest Expense
69K
Selling & Marketing Expenses
n/a
Cost & Expenses
40.65M
Income Tax Expense
69K
Shares Outstanding (Basic)
1.78M
Shares Outstanding (Diluted)
1.78M
EPS (Basic)
-22.16
EPS (Diluted)
-22.16
EBITDA
-40.24M
EBIT
-39.41M
Depreciation & Amortization
22K